Effectiveness of early lens extraction for the treatment of primary angle-closure glaucoma (eagle): a randomised controlled trial

References
1 
WHO. Global Data on Visual Impairments 2010 
(WHO/NMH/PBD/12.01). Geneva: World Health Organization, 2012.
2 
Tham YC, Li X, Wong TY, Quigley HA, Aung T, Cheng CY. 
Global prevalence of glaucoma and projections of glaucoma burden 
through 2040: a systematic review and meta-analysis. 
Ophthalmology 2014; 121: 2081–90.
3 
Day AC, Baio G, Gazzard G, et al. The prevalence of primary angle 
closure glaucoma in European derived populations: a systematic 
review. Br J Ophthalmol 2012; 96: 1162–67.
4 
Frick KD, Gower EW, Kempen JH, Wolff JL. Economic impact of 
visual impairment and blindness in the United States. 
Arch Ophthalmol 2007; 125: 544–50.
5 
Varma R, Lee PP, Goldberg I, Kotak S. An assessment of the health and 
economic burdens of glaucoma. Am J Ophthalmol 2011; 152: 515–22.
6 
Weinreb RN, Aung T, Medeiros FA. The pathophysiology and 
treatment of glaucoma: a review. JAMA 2014; 311: 1901–11.
7 
American Academy of Ophthalmology Glaucoma Panel. Preferred 
practice pattern
®
guidelines. Primary angle closure. San Francisco, 
CA: American Academy of Ophthalmology, 2015.
8 
Gunning FP, Greve EL. Lens extraction for uncontrolled angle-closure 
glaucoma: long-term follow-up. J Cataract Refract Surg 1998; 24: 1347–56.
9 
Friedman DS, Vedula SS. Lens extraction for chronic angle-closure 
glaucoma. Cochrane Database Syst Rev 2009; 3: CD005555.
10 Shen L, Melles RB, Metlapally R, et al. The association of refractive 
error with glaucoma in a multiethnic population. Ophthalmology 
2016; 123: 92–101.
11 
Azuara-Blanco A, Burr JM, Cochran C, et al, for the Eff ectiveness in 
Angle-closure Glaucoma of Lens Extraction (EAGLE) Study Group. The 
eff ectiveness of early lens extraction with intraocular lens implantation 
for the treatment of primary angle-closure glaucoma (EAGLE): study 
protocol for a randomized controlled trial. Trials 2011; 12: 133–42.
12 Scott NW, McPherson GC, Ramsay CR, Campbell MK. The method 
of minimization for allocation to clinical trials. A review. 
Control Clin Trials 2002; 23: 662–74.
13 EuroQol Group. EuroQol—a new facility for the measurement of 
health-related quality of life. Health Policy 1990; 16: 199–208.
14 Dolan P, Gudex C, Kind P, Williams A. A social tariff for EuroQol: 
results from a UK general population survey. York: University of 
York, 1995.
15 EuroQol. EQ-5D-3L Value sets. http://www.euroqol.org/about-eq-5d/
valuation-of-eq-5d/eq-5d-3l-value-sets.html (accessed June 15, 2016). 
16 Department of Health. NHS reference costs 2012 to 2013. 
Nov 21, 2013. https://www.gov.uk/government/publications/
nhs-reference-costs-2012-to-2013 (accessed June 17, 2016).
17 Personal Social Services Research Unit. Unit Costs of Health and 
Social Care 2013. http://www.pssru.ac.uk/project-pages/unit-
costs/2013/ (accessed June 17, 2016).
18 Royal Pharmaceutical Society. British National Formulary 61. 
London: Royal Pharmaceutical Society, 2011.
19 Mangione CM, Lee PP, Gutierrez PR, Spritzer K, Berry S, Hays RD, 
for the National Eye Institute. Development of the 25-item 
National Eye Institute Visual Function Questionnaire. 
Arch Ophthalmol 2001; 119: 1050–58.
20 Mangione CM, Lee PP, Pitts J, Gutierrez P, Berry S, Hays RD. 
Psychometric properties of the National Eye Institute Visual 
Function Questionnaire (NEI-VFQ). NEI-VFQ fi eld test 
investigators. Arch Ophthalmol 1998; 116: 1496–504.
21 Burr JM, Kilonzo M, Vale L, Ryan M. Developing a preference-based 
glaucoma utility index using a discrete choice experiment. 
Optom Vis Sci 2007; 84: 797–808.
22 Ferris FL 3rd, Kassoff A, Bresnick GH, Bailey I. New visual acuity 
charts for clinical research. Am J Ophthalmol 1982; 94: 91–96.
23 Brusini P, Filacorda S. Enhanced glaucoma staging system (GSS 2) for 
classifying functional damage in glaucoma. J Glaucoma 2006; 15: 40–46.
24 Hayashi K, Hayashi H, Nakao F, Hayashi F. Changes in anterior 
chamber angle width and depth after intraocular lens implantation 
in eyes with glaucoma. Ophthalmology 2000; 107: 698–703.
25 Liu CJ, Cheng CY, Wu CW, Lau LI, Chou JC, Hsu WM. 
Factors predicting intraocular pressure control after 
phacoemulsifi cation in angle-closure glaucoma. 
Arch Ophthalmol 2006; 124: 1390–94.
26 Nonaka A, Kondo T, Kikuchi M, et al. Angle widening and alteration 
of ciliary process confi guration after cataract surgery for primary 
angle closure. Ophthalmology 2006; 113: 437–41.
27 Goldstein H. Multilevel statistical models, 2nd edn. London: 
Arnold, 1996.
28 National Institute for Health and Care Excellence. Process and 
methods guides: guide to the methods of technology appraisal 2013. 
April 4, 2013. http://www.nice.org.uk/article/pmg9/resources/non-
guidance-guide-to-the-methods-of-technology-appraisal-2013-pdf 
(accessed June 17, 2016).
29 StataCorp. Stata multiple-imputation reference manual release 12. 
College Station, TX: StataCorp, 2012.
30 Day AC, Donachie PH, Sparrow JM, Johnston RL, for the Royal 
College of Ophthalmologists’ National Ophthalmology Database. 
The Royal College of Ophthalmologists’ National Ophthalmology 
Database study of cataract surgery: report 1, visual outcomes and 
complications. Eye 2015; 29: 552–60.